✦ LIBER ✦

A qualitative and quantitative analysis of von Willebrand factor contained in a very high-purity plasma-derived FVIII concentrate

✍ Scribed by B. Samor; C. Michalski; M.-P. Brandin; M.-H. Andre; S. Chtourou; Z. Tellier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro Evaluation of a Very-High-Purit

✍ Claudine Mazurier; Sylvie Jorieux; Christophe de Romeuf; Bruno Samor; Maurice Go 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 1009 KB

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

The use of a single von Willebrand facto

✍ M. KURTH; J. PUETZ; P. KOUIDES; J. SANDERS; C. SEXAUER; J. BERNSTEIN; R. GRUPPO; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Experience with Optivate®, a new high pu

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Clinical assessment of Optivate®, a high

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Efficacy and safety of a high purity, do

✍ J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB